Table 1.
Characteristics of cancer and non-cancer participants included in this study.
| Characteristics | Participants, n = 140 | |
|---|---|---|
| Biopsy Result | Non-Cancer 70 (50%) | Prostate Cancer 70 (50%) |
|
Age Average (range) ≤60 year >60 year |
60.2 (49–77) 37 (53%) 33 (47%) |
64.1 (40–79) 27 (39%) 43 (61%) |
|
tPSA (ng/mL) Average (range) ≤3 3–5 ≥5 |
5.4 (2.5–10.7) 6 (9%) 26 (37%) 38 (54%) |
5.5 (2.3–9.8) 6 (9%) 26 (37%) 38 (54%) |
|
Prostate volume (mL) ≤35 35–50 >50 |
13 (19%) 17 (24%) 40 (57%) |
29 (41%) 21 (30%) 20 (29%) |
|
Biopsy results Gleason score (patterns) 6 (3 + 3) 7 (3 + 4) 7 (4 + 3) 8 (3 + 5) 9 (4 + 5) 10 (5 + 5) Prostatitis Atrophy Benign hyperplasia High-grade PIN Previous biopsy Follow-up carcinoma (ReDX) |
NA NA NA NA NA NA 43 (61%) 20 (29%) 28 (40%) 2 (3%) 11 (16%) 1 |
28 (40%) 27 (39%) 3 (4%) 7 (10%) 4 (6%) 1 (1%) 12 (17%) 18 (26%) 6 (9%) 3 (4%) 3 (4%) NA |
|
Tumor risk groups Gleason score |
||
| Low grade GS = 6 | NA | 28 (40%) |
| Significant GS ≥ 7 | NA | 42 (60%) |
NA: not applicable; ReDX: patient originally in the non-cancer cohort re-diagnosed as a PCa patient.